Morbid Rates After Spiriva Chronic Obstructive Pulmonary Disease (COPD) Protocol Change

NCT06053541 · clinicaltrials.gov ↗

COMPLETED

Status

3015000

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Sponsor

Boehringer Ingelheim